TransMedics, Inc. has announced that the FDA approved its Pre-Market Approval Application (PMA) for the Organ Care System (OCS) Lung platform for the standard double lung transplant indication. The INSPIRE Trial that supported the PMA was the first and largest controlled clinical organ preservation trial ever in lung transplantation and was conducted at 21 leading international academic institutions.